Prof. Dr. David Baud is presently head of the obstetric service at the Lausanne University Hospital (CHUV), Switzerland. He is board-certified in Obstetrics & Gynecology and operative Gynecology. After his PhD, he trained as a postdoc in the Institute of Microbiology (CHUV). He then trained at various hospitals worldwide including St-Mary’s Hospital in London, UK (2004-2005), Tu Du Hospital in Saigon/Vietnam (2007, 60,000 deliveries/year), Hopital Necker in Paris (2009-2010), and Mount Sinai Hospital in Toronto (2010-2012). He started his research lab in 2013. His current research focuses on emerging infectious causes of infertility and adverse pregnancy outcomes. Thanks to his clinical expertise in fetal medicine, research expertise in emerging infectious diseases, and collaborations worldwide, he has also developed a specific interest in emerging viruses (such as Monkeypox, SARS-CoV-2, and Zika). His research groups are both involved in clinical and laboratory research.
Prof. Dr. David Baud is presently head of the obstetric service at the Lausanne University Hospital (CHUV), Switzerland. He is board-certified in Obstetrics & Gynecology and operative Gynecology. After his PhD, he trained as a postdoc in the Institute of Microbiology (CHUV). He then trained at various hospitals worldwide including St-Mary’s Hospital in London, UK (2004-2005), Tu Du Hospital in Saigon/Vietnam (2007, 60,000 deliveries/year), Hopital Necker in Paris (2009-2010), and Mount Sinai Hospital in Toronto (2010-2012). He started his research lab in 2013. His current research focuses on emerging infectious causes of infertility and adverse pregnancy outcomes. Thanks to his clinical expertise in fetal medicine, research expertise in emerging infectious diseases, and collaborations worldwide, he has also developed a specific interest in emerging viruses (such as Monkeypox, SARS-CoV-2, and Zika). His research groups are both involved in clinical and laboratory research.